Market openNon-fractional

Maravai LifeSciences/MRVI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Maravai LifeSciences

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Ticker

MRVI

Sector

Healthcare

Trading on

NASDAQ

Industry

Life Sciences Tools and Services

Headquarters

San Diego, United States

Employees

570

MRVI Metrics

BasicAdvanced
$928M
Market cap
-
P/E ratio
-$0.99
EPS
0.03
Beta
-
Dividend rate
$928M
0.03
11.316
10.186
77.906
77.349
-1.05%
-1.56%
-19.04%
3.368
2.26
-7.15
-30.102
-61.81%
-185.20%
-10.42%
11.95%

What the Analysts think about MRVI

Analyst Ratings

Majority rating from 13 analysts.
Buy

MRVI Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-18.72% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$64M
-13.50%
Net income
-$12M
-88.67%
Profit margin
-18.72%
-86.90%

MRVI Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 21.43%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-
-$0.01
$0.01
-$0.02
-
Expected
$0.01
$0.01
-$0.01
-$0.03
$0.00
Surprise
-
-257.13%
-184.62%
-21.43%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Maravai LifeSciences stock?

Maravai LifeSciences (MRVI) has a market cap of $928M as of July 05, 2024.

What is the P/E ratio for Maravai LifeSciences stock?

The price to earnings (P/E) ratio for Maravai LifeSciences (MRVI) stock is 0 as of July 05, 2024.

Does Maravai LifeSciences stock pay dividends?

No, Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Maravai LifeSciences dividend payment date?

Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders.

What is the beta indicator for Maravai LifeSciences?

Maravai LifeSciences (MRVI) has a beta rating of 0.03. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Maravai LifeSciences stock

Buy or sell Maravai LifeSciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing